Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 4
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,610 | Dovepress* | 5,610+ | 1,675 | 7,285 | |
Totals | 5,610 | 1,675 | 7,285 | ||
*Since 5 December 2008 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 1 |
View citations on Google Scholar